PortfoliosLab logo

Aquestive Therapeutics, Inc. (AQST)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Aquestive Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $710 for a total return of roughly -92.90%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%NovemberDecember2023FebruaryMarch
-92.90%
44.39%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AQST

Aquestive Therapeutics, Inc.

Return

Aquestive Therapeutics, Inc. had a return of 26.39% year-to-date (YTD) and -57.46% in the last 12 months. Over the past 10 years, Aquestive Therapeutics, Inc. had an annualized return of -43.18%, while the S&P 500 had an annualized return of 8.17%, indicating that Aquestive Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month45.59%3.51%
Year-To-Date26.39%7.03%
6 months1.79%12.88%
1 year-57.46%-10.71%
5 years (annualized)-43.18%8.17%
10 years (annualized)-43.18%8.17%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-1.33%-12.02%
2022-19.03%-25.64%6.67%-2.80%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aquestive Therapeutics, Inc. Sharpe ratio is -0.66. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.66
-0.46
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Aquestive Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-93.99%
-14.33%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aquestive Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aquestive Therapeutics, Inc. is 96.68%, recorded on Jul 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.68%Sep 10, 2018960Jul 1, 2022
-6.54%Jul 26, 20188Aug 6, 20185Aug 13, 201813
-6.17%Aug 15, 20189Aug 27, 20182Aug 29, 201811
-0.67%Sep 4, 20181Sep 4, 20182Sep 6, 20183

Volatility Chart

Current Aquestive Therapeutics, Inc. volatility is 80.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%NovemberDecember2023FebruaryMarch
80.16%
15.42%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)